GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuroscientific Biopharmaceuticals Ltd (ASX:NSB) » Definitions » Interest Paid

Neuroscientific Biopharmaceuticals (ASX:NSB) Interest Paid : A$0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Neuroscientific Biopharmaceuticals Interest Paid?

Neuroscientific Biopharmaceuticals's Interest Paid for the six months ended in Dec. 2024 was A$0.00 Mil.

Neuroscientific Biopharmaceuticals's Interest Paid for the trailing twelve months (TTM) ended in Dec. 2024 was A$0.00 Mil.

Neuroscientific Biopharmaceuticals Interest Paid Historical Data

The historical data trend for Neuroscientific Biopharmaceuticals's Interest Paid can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuroscientific Biopharmaceuticals Interest Paid Chart

Neuroscientific Biopharmaceuticals Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Interest Paid
Get a 7-Day Free Trial - - - - -

Neuroscientific Biopharmaceuticals Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Interest Paid Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Neuroscientific Biopharmaceuticals Interest Paid Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Interest Paid represents interest paid on loans, debt or borrowings, in the direct cash flow method.

Interest Paid for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neuroscientific Biopharmaceuticals Interest Paid Related Terms

Thank you for viewing the detailed overview of Neuroscientific Biopharmaceuticals's Interest Paid provided by GuruFocus.com. Please click on the following links to see related term pages.

Neuroscientific Biopharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuroscientific Biopharmaceuticals Ltd (ASX:NSB) » Definitions » Interest Paid
Comparable Companies
ASX:ZLD ASX:1AD ASX:IXC ASX:CMB ASX:PAB ASX:BGT ASX:VBS ASX:BIT ASX:1AI ASX:CHM VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
a Street, Suite 5, Cottesloe, Perth, WA, AUS, 6011
Website
https://www.neuroscientific.com
Neuroscientific Biopharmaceuticals Ltd is an Australian-based biotechnology company. The company is engaged in the development of diagnostic and therapeutic treatments for neurodegenerative diseases through preclinical studies of patented technologies.

Neuroscientific Biopharmaceuticals Headlines

No Headlines